Drug intelligence / Profile preview

Zhenqi Liujun

Development stage: Preclinical
Lead developer: Sichuan Administration of Traditional Chinese Medicine
Administration: Oral

Overview

Zhenqi Liujun is a Traditional Chinese Medicine (TCM) in granule form, specifically designated as an "Anti cancer Granule". It is being investigated as an intervention in combination with radiochemotherapy for the treatment of cervical carcinoma. As a TCM formula, it is likely composed of multiple herbal ingredients, aiming to support the body's response to cancer treatment and potentially exert direct anti-cancer effects.

Other names: Zhenqi Liujun Anti cancer Granule

Beyond the preview

Go deeper on Zhenqi Liujun.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhenqi Liujun.

Explore the full profile